Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Nosbaum

Showing results (31-40 of 40) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 40 results.
Journal of the European Academy of Dermatology and Venereology : JEADV|May 12, 2023
T cell-and non T cell-mediated delayed hypersensitivity to dupilumabA R de Magalhães, G U Machado, M A Lefèvre, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|July 17, 2016
Comparative histological analysis of drug-induced maculopapular exanthema and DRESSF Skowron, B Bensaid, B Balme, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|September 11, 2015
Drug reaction with eosinophilia and systemic symptoms (DRESS): clinicopathological study of 45 casesF Skowron, B Bensaid, B Balme, et al.
Allergy|March 22, 2025
Allergic Signature in Delayed Cross-Hypersensitivity to all Iodinated Contrast MediaD Do, L Bertolotti, A Mosnier, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|September 19, 2019
Effectiveness and safety of dupilumab for the treatment of prurigo nodularis in a French multicenter adult cohort of 16 patientsA Calugareanu, M Jachiet, M Tauber, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|February 17, 2021
Dupilumab-associated hypereosinophilia in patients treated for moderate-to-severe atopic dermatitisP Marcant, P Balayé, R Merhi, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|July 6, 2019
Low cardiovascular risk and poor quality of life associated with tobacco use and skin infections in adult atopic dermatitis: result of a French multicenter studyM Jachiet, A Nosbaum, D Staumont-Sallé, et al.
The British Journal of Dermatology|November 8, 2021
Reasons for discontinuation of dupilumab in adult atopic dermatitis in clinical practiceM-E Marniquet, J Seneschal, A-S Darrigade, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|July 20, 2022
Effectiveness and safety of dupilumab in the treatment of atopic dermatitis in children (6-11 years): data from a French multicentre retrospective cohort in daily practiceA Lasek, N Bellon, S Mallet, et al.
The Journal of Allergy and Clinical Immunology. in Practice|November 29, 2025
Eczema following IL-5 inhibitors for the treatment of severe asthma with improvement after switching to an IL-4Rα mAbG U Machado, V Bourdenet, G Devouassoux, et al.
Pageof 4

Showing results (31-40 of 40) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 40 results.
Journal of the European Academy of Dermatology and Venereology : JEADV|May 12, 2023
T cell-and non T cell-mediated delayed hypersensitivity to dupilumabA R de Magalhães, G U Machado, M A Lefèvre, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|July 17, 2016
Comparative histological analysis of drug-induced maculopapular exanthema and DRESSF Skowron, B Bensaid, B Balme, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|September 11, 2015
Drug reaction with eosinophilia and systemic symptoms (DRESS): clinicopathological study of 45 casesF Skowron, B Bensaid, B Balme, et al.
Allergy|March 22, 2025
Allergic Signature in Delayed Cross-Hypersensitivity to all Iodinated Contrast MediaD Do, L Bertolotti, A Mosnier, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|September 19, 2019
Effectiveness and safety of dupilumab for the treatment of prurigo nodularis in a French multicenter adult cohort of 16 patientsA Calugareanu, M Jachiet, M Tauber, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|February 17, 2021
Dupilumab-associated hypereosinophilia in patients treated for moderate-to-severe atopic dermatitisP Marcant, P Balayé, R Merhi, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|July 6, 2019
Low cardiovascular risk and poor quality of life associated with tobacco use and skin infections in adult atopic dermatitis: result of a French multicenter studyM Jachiet, A Nosbaum, D Staumont-Sallé, et al.
The British Journal of Dermatology|November 8, 2021
Reasons for discontinuation of dupilumab in adult atopic dermatitis in clinical practiceM-E Marniquet, J Seneschal, A-S Darrigade, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|July 20, 2022
Effectiveness and safety of dupilumab in the treatment of atopic dermatitis in children (6-11 years): data from a French multicentre retrospective cohort in daily practiceA Lasek, N Bellon, S Mallet, et al.
The Journal of Allergy and Clinical Immunology. in Practice|November 29, 2025
Eczema following IL-5 inhibitors for the treatment of severe asthma with improvement after switching to an IL-4Rα mAbG U Machado, V Bourdenet, G Devouassoux, et al.
Pageof 4